FIRINOX

Wakayama Medical University · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	FIRINOX
Also known as	Oxaliplatin, Irinotecan, 5-FU.
Sponsor	Wakayama Medical University
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FIRINOX CI brief — competitive landscape report
FIRINOX updates RSS · CI watch RSS
Wakayama Medical University portfolio CI